BAL is often associated with the translocation t(8;14)(q24;q32) or its variants; the molecular genetics of BAL is characterised by myelocytomatosis oncogene (MYC) rearrangements (MYCr), and it is considered the leukaemic phase of Burkitt lymphoma (BL) [6, 7]. Here, MYC is linked to Burkitt lymphoma.